Hinge Health Inc. has reached a significant milestone as its stock hit an all-time high of $107.08. The stock has surged more than 250% from its 52-week low of $30.08, with particularly strong momentum in recent months—up 137% over the past six months alone. This achievement underscores a remarkable year for the company, with its stock experiencing a substantial 114.48% increase over the past year. The surge reflects strong investor confidence and the company’s robust performance in the digital health sector, supported by impressive revenue growth of nearly 50% over the last twelve months.
In other recent news, Hinge Health has seen a series of positive developments. Truist Securities has raised its price target for the company to $112, reflecting an updated financial model that considers Hinge Health’s second-quarter earnings results and its revised outlook. The firm now anticipates revenue of $860 million for fiscal 2026 and $1,095 million for fiscal 2027. Stifel has also increased its price target to $115 from $96, citing a strong growth outlook and projecting above-consensus growth of over 33% by 2027.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.